NO20056199L - Kaptoprilderivater - Google Patents

Kaptoprilderivater

Info

Publication number
NO20056199L
NO20056199L NO20056199A NO20056199A NO20056199L NO 20056199 L NO20056199 L NO 20056199L NO 20056199 A NO20056199 A NO 20056199A NO 20056199 A NO20056199 A NO 20056199A NO 20056199 L NO20056199 L NO 20056199L
Authority
NO
Norway
Prior art keywords
captopril
captoprilnitro
prophylaxis
cardiovascular
inflammatory
Prior art date
Application number
NO20056199A
Other languages
English (en)
Inventor
Piero Del Soldato
Ennio Ongini
Nicoletta Almirante
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of NO20056199L publication Critical patent/NO20056199L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Kaptoprilnitroderivater med forbedret farmakologisk aktivitet og økt tolererbarhet kan benyttes til behandling eller profylakse av kardiovasku-lære, inflammatoriske og renale sykdommer .
NO20056199A 2003-05-28 2005-12-27 Kaptoprilderivater NO20056199L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101553 2003-05-28
PCT/EP2004/050899 WO2004106300A1 (en) 2003-05-28 2004-05-24 Captopril derivatives

Publications (1)

Publication Number Publication Date
NO20056199L true NO20056199L (no) 2006-02-13

Family

ID=33483995

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056199A NO20056199L (no) 2003-05-28 2005-12-27 Kaptoprilderivater

Country Status (15)

Country Link
US (1) US7169805B2 (no)
EP (1) EP1626955A1 (no)
JP (1) JP4649410B2 (no)
KR (1) KR20060013413A (no)
CN (1) CN1795173A (no)
AR (1) AR044568A1 (no)
AU (1) AU2004242799A1 (no)
BR (1) BRPI0410020A (no)
CA (1) CA2527382A1 (no)
MX (1) MXPA05012758A (no)
NO (1) NO20056199L (no)
PL (1) PL379168A1 (no)
RU (1) RU2005135695A (no)
WO (1) WO2004106300A1 (no)
ZA (1) ZA200509459B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006027711A2 (en) 2004-08-26 2006-03-16 Nicholas Piramal India Limited Prodrugs and codrugs containing bio- cleavable disulfide linkers
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
WO2011160974A2 (en) 2010-06-21 2011-12-29 Nicox S.A. Statin derivatives

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
JPS559058A (en) 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
US4399144A (en) 1980-04-30 1983-08-16 John Wyeth And Brother Limited Pyridinium salts
EP0432204A4 (en) 1988-08-26 1992-08-12 Sepracor, Inc. Derivatives and precursors of captopril and its analogues
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
CA2182198A1 (en) 1994-01-28 1995-08-03 William Byrne A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
GB9517998D0 (en) * 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
IT1276071B1 (it) 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
JPH09291075A (ja) * 1996-03-01 1997-11-11 Sankyo Co Ltd チアゾリジン類
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
IT1295694B1 (it) 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1292426B1 (it) 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
JPH1171279A (ja) 1997-08-27 1999-03-16 Sankyo Co Ltd チアゾリジン類を有効成分として含有する狭心症予防剤又は治療剤
US6223744B1 (en) * 1999-03-16 2001-05-01 Multi-Vet Ltd. Wearable aerosol delivery apparatus
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
WO2001013900A2 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
CA2382549C (en) * 1999-08-30 2005-03-15 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
WO2002034303A1 (en) * 2000-10-27 2002-05-02 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
BR0017074A (pt) * 2000-01-26 2002-12-03 Warner Lambert Co Combinações de inibidor de ace-antagonista de vasopressina
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie

Also Published As

Publication number Publication date
US20040259808A1 (en) 2004-12-23
CN1795173A (zh) 2006-06-28
RU2005135695A (ru) 2006-05-27
ZA200509459B (en) 2006-11-29
WO2004106300A1 (en) 2004-12-09
US7169805B2 (en) 2007-01-30
JP2006528230A (ja) 2006-12-14
BRPI0410020A (pt) 2006-04-25
AR044568A1 (es) 2005-09-21
KR20060013413A (ko) 2006-02-09
MXPA05012758A (es) 2006-02-13
EP1626955A1 (en) 2006-02-22
CA2527382A1 (en) 2004-12-09
JP4649410B2 (ja) 2011-03-09
PL379168A1 (pl) 2006-07-24
AU2004242799A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
SG161318A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
IS7684A (is) Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
EA200870019A1 (ru) Лактамовые соединения и способы их применения
NO20070782L (no) Tetrapeptidanaloger.
IS7840A (is) 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum
CL2009000200A1 (es) Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune.
DK1352896T3 (da) Adamantanderivater til behandling af inflammations-, immun- og hjertekarsygdomme
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
WO2007044534A3 (en) Vegf analogs and methods of use
NO20081349L (no) Pyrrolopyrimidinderivater som Syk-inhibitorer
DK1761266T3 (da) Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
ATE448232T1 (de) Substituierte heterozyklen
WO2002060374A3 (en) Benz-1,3-azole derivatives and their uses as heparanase inhibitors
PH12020551573A1 (en) Pharmaceutical compositions for inhibiting inflammatory cytokines
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
TW200740755A (en) Dihalogenation of N,O-disubstituted hydroxypyridones and their uses
ATE433459T1 (de) Desoxo-nonadepsipeptide
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
NO20082838L (no) 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application